Skip to main content
SpringerLink
Log in

Prävention kardiovaskulärer Ereignisse

Heart Outcomes Prevention Evaluation (HOPE)

Prevention of cardiovascular events

Heart Outcomes Prevention Evaluation (HOPE)

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Cholesterol Treatment Trialists’ Collaborators (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267–1278

    Article  Google Scholar 

  2. The ACCORD Study Group (2010) Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med 362:1575–1585

    Article  PubMed Central  Google Scholar 

  3. The SPRINT Research Group (2015) A randomized trial of intensive versus standard blood pressure control. N Engl J Med 373:2103–2116

    Article  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstr. 36, 80636, München, Deutschland

    W. Koenig FRCP, FACC, FAHA, FESC

  2. Lippetal, Deutschland

    S. Nitschmann

Authors
  1. W. Koenig FRCP, FACC, FAHA, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Koenig FRCP, FACC, FAHA, FESC.

Ethics declarations

Interessenkonflikt

W. Koenig ist als Referent für AstraZeneca sowie Novartis tätig und erhält Beraterhonorare von Pfizer und Novartis. S. Nitschmann gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

M. Hallek, Köln

W. Lehmacher, Köln

N. Marx, Aachen

U. Müller-Ladner, Bad Nauheim

H. Wedemeyer, Hannover

M. Wehling, Mannheim

T.R. Weihrauch, Düsseldorf

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koenig, W., Nitschmann, S. Prävention kardiovaskulärer Ereignisse. Internist 57, 1250–1253 (2016). https://doi.org/10.1007/s00108-016-0155-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-016-0155-2

Search

Navigation